Drug profile · INN
human hepatitis b immunoglobulin
ZUTECTRA
human hepatitis b immunoglobulin (ZUTECTRA) is a surface antigen (hbsag) binding agent.
EMA: approved Antiinfectives for systemic use (J06) J06BB04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — human hepatitis b immunoglobulin
- Class
- Antiinfectives for systemic use (J06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
human hepatitis b immunoglobulin (ZUTECTRA) is a surface antigen (hbsag) binding agent.
Key facts
INN human hepatitis b immunoglobulin
Brand ZUTECTRA
Mechanism Surface antigen (HBsAg) binding agent
Target Surface antigen (HBsAg)
Therapeutic class Antiinfectives for systemic use (J06)
ATC code J06BB04
Mechanism of action
Surface antigen (HBsAg) binding agent
Primary target: Surface antigen (HBsAg)
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is human hepatitis b immunoglobulin?
human hepatitis b immunoglobulin (ZUTECTRA) is a surface antigen (hbsag) binding agent.
What is the brand name for human hepatitis b immunoglobulin?
ZUTECTRA is a marketed brand name for human hepatitis b immunoglobulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.